NCT02288845View on ClinicalTrials.gov

Receptor Occupancy of ITI-007 Using Positron Emission Tomography (PET) in Patients With Stable Schizophrenia

PHASE2CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

July 31, 2015

Study Completion Date

September 30, 2015

Conditions
Schizophrenia
Interventions
DRUG

ITI-007

Trial Locations (1)

21287

Johns Hopkins Medical Institutions, Baltimore

Sponsors
All Listed Sponsors
lead

Intra-Cellular Therapies, Inc.

INDUSTRY